[1] Eberle R, Jones-Engel L. Questioning the extreme neurovirulence of monkey B virus (Macacine alphaherpesvirus 1). Adv Virol 2018;2018:5248420. http://dx.doi.org/10.1155/2018/5248420CrossRef
[2] Holmes GP, Hilliard JK, Klontz KC, Rupert AH, Schindler CM, Parrish E, et al. B virus (Herpesvirus simiae) infection in humans: epidemiologic investigation of a cluster. Ann Intern Med 1990;112(11):833 − 9. http://dx.doi.org/10.7326/0003-4819-112-11-833CrossRef
[3] Perelygina L, Patrusheva I, Manes N, Wildes MJ, Krug P, Hilliard JK. Quantitative real-time PCR for detection of monkey B virus (Cercopithecine herpesvirus 1) in clinical samples. J Virol Methods 2003;109(2):245 − 51. http://dx.doi.org/10.1016/s0166-0934(03)00078-8CrossRef
[4] Sugita S, Shimizu N, Watanabe K, Mizukami M, Morio T, Sugamoto Y, et al. Use of multiplex PCR and real-time PCR to detect human herpes virus genome in ocular fluids of patients with uveitis. Br J Ophthalmol 2008;92(7):928 − 32. http://dx.doi.org/10.1136/bjo.2007.133967CrossRef
[5] Ye F, Song JD, Zhao L, Zhang Y, Xia LX, Zhu LW, et al. Molecular evidence of human monkeypox virus infection, Sierra Leone. Emerg Infect Dis 2019;25(6):1220 − 2. http://dx.doi.org/10.3201/eid2506.180296CrossRef